SKIL and neoplasm: SKI may also localize in the cytoplasm of tumor cells [17], where it may interfere with TGF-β signaling by sequestering SMAD proteins and preventing their nuclear accumulation in response to TGF-β, as we demonstrated in the case of SnoN [18].